Susanne Schaffert, PhD was appointed Chairperson and President of Advanced Accelerator Applications (AAA) in January 2018, following the completion of a tender offer for the company by Novartis.

Prior to this, Dr. Schaffert was the Head of Region Europe at Novartis Oncology, where she was responsible for leading Novartis’ Oncology Business Unit in the European Region, marketing key products in lung, breast and renal cancer as well as hematology and coordinating the entire Oncology operations for EU countries.

She is a member of the Novartis Oncology Executive Committee and R&D Portfolio management board, as well as a member of the Board of Novartis AG Germany and the GSK JV OTC Board.

From 2010 to 2012, Dr. Schaffert served as the Head of Investor Relations for Novartis Group, reporting to the Chief Financial Officer. Before this, she served as Novartis Global Franchise Head for Immunology and Infectious Diseases.

She first joined Novartis Germany in 1995, as a sales representative, and has held a series of positions in Sales & Marketing with increasing responsibilities in both National and Global functions. Her roles have included Global Brand Director, Basel; Head of Marketing Oncology, Germany; Business Unit Head Oncology, Germany and Head of Northern & Central Europe for Novartis Oncology, managing a $1 billion business with more than 500 associates.

Dr. Schaffert holds a PhD with honors in Organic Chemistry from University of Erlangen (Germany).